L. Beauregard-Zollinger

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
L Beauregard-zollinger, Lyse Beauregard-zollinger
Publication record
15 papers · 421 citations · H-index 10

PAPERS

Randomized, International Study of Cyclosporine Microemulsion Absorption Profiling in Renal Transplantation with Basiliximab Immunoprophylaxis
200281 citationsauthor #10
Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse‐sample Predictors During the First 3 Months after Renal Transplantation
2002141 citationsauthor #10
IMPROVED CLINICAL OUTCOMES FOR LIVER TRANSPLANT RECIPIENTS USING CYCLOSPORINE BLOOD LEVEL MONITORING BASED ON TWO‐HOUR POST‐DOSE LEVELS.: Abstract# 1059
200027 citationsauthor #3
SHORT‐TERM COMBINATION OF MYCOPHENOLATE MOFETIL WITH CYCLOSPORINE AS A SAFE THERAPEUTIC OPTION FOR RENAL TRANSPLANT RECIPIENTS.: Abstract# 182 Poster Board #‐Session: P29‐I
20002 citationsauthor #3
ABSORPTION PROFILING OF CYCLOSPORINE THERAPY FOR DE NOVO KIDNEY TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED STUDY COMPARING SPARSE SAMPLING TO TROUGH MONITORING.: Abstract# 190 Poster Board #‐Session: P37‐I
200037 citationsauthor #3
102Improved clinical outcomes for liver transplant recipients using cyclosporin blood level monitoring two hours post dosage
20000 citationsauthor #3
SHORT-TERM MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE COMPARED TO STANDARD MAINTENANCE REGIMENS OF CYCLOSPORINE WITH MYCOPHENOLATE MOFETIL OR AZATHIOPRINE IN KIDNEY TRANSPLANTATION: INTERIM ANALYSIS
19992 citationsauthor #3
Economic analysis of Neoral in de novo renal transplant patients in Canada
199714 citationsauthor #6
Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
199615 citationsauthor #2
Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat.
19964 citationsauthor #6
Economic analysis of Sandimmune Neoral in Canada in stable renal transplant patients.
199514 citationsauthor #4
Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients.
199419 citationsauthor #3
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
199322 citationsauthor #8
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
19932 citationsauthor #9
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
199341 citationsauthor #9

TIMELINE

1993 65 citations

1994 19 citations

1995 14 citations

1996 19 citations

1997 14 citations

1999 2 citations

2000 66 citations

2002 222 citations

L. Beauregard-Zollinger

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT